© 2021 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
Neurology
The neurologic impact of COVID-19 on pediatric patients
March 10, 2021
Coronavirus disease 2019 (COVID-19) is more than a disease that attacks the respiratory system. An investigation examines the neurologic involvement during COVID-19.
Does type 1 diabetes impact on the brain persist into puberty?
March 03, 2021
Previous research has shown that type 1 diabetes can impact the brain. A study examines whether this impact can persist or even worsen.
Examining the neurological manifestations of COVID-19
January 26, 2021
An investigation looks at the neurological manifestations of COVID-19.
Looking at outcomes a year after concussion
January 18, 2021
How well do children recover from a concussion? A report offers some answers.
Using parental reports of symptoms in children with severe neurological impairment
December 30, 2020
A report examines how parental symptom reports could impact medication needs to children with severe neurological impairment.
FDA approves Xeomin (incobotulinumtoxinA) for chronic sialorrhea
December 21, 2020
The FDA approves Xeomin (incobotulinumtoxinA) for chronic sialorrhea in children.
A case of acute psychosis that will make your head spin
December 11, 2020
A 12-year-old previously healthy male was transferred to a children's hospital from a psychiatric unit for new onset psychosis and an abnormal electroencephalogram. What's the diagnosis?
Effects of childhood lead exposure on the brain seen in midlife
November 24, 2020
A new investigation reports on the long-term effect of lead exposure found in brain imaging of midlife adults.
What impacts the concussion recovery process?
November 19, 2020
Over the past couple of decades, the recovery process for concussions have changed. A report looks at what factors could impact a pediatric patient’s recovery process.
Does prenatal exposure to valproate increase risk of intellectual disability?
November 18, 2020
An investigation looks at whether prenatal exposure to antiepileptics such as valproate are linked to risk of intellectual disability.